Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 149 articles: HTML format

Single Articles

February 2026
1. YAMAMOTO A, Asaoka M, Horimoto Y, Yamada A, et al
   Clinicopathological predictors of distant recurrence in breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy.
   Eur J Surg Oncol. 2026;52:111508.
   PubMed     Abstract available
   
   
   
2. VERHEUL EM, Karsten MM, Gebert P, Doppelbauer L, et al
   Development and validation of prediction models for health-related quality of life outcomes after breast cancer surgery and reconstruction.
   Eur J Surg Oncol. 2026;52:111466.
   PubMed     Abstract available
   
   
   
3. ZHANG C, Lodi M
   Immediate and delayed lymphatic reconstruction of breast-cancer related lymphedema: A systematic review and network meta-analysis.
   Eur J Surg Oncol. 2026;52:111394.
   PubMed     Abstract available
   
   
   
4. EL-HALLAK H, Garvey LH, Tvedskov TF, Holmich LR, et al
   Perioperative hypersensitivity reactions to Patent Blue V in sentinel lymph node biopsy for breast cancer and melanoma.
   Eur J Surg Oncol. 2026;52:111459.
   PubMed     Abstract available
   
   
   
5. LIAO N, Liu N, Zhang G, Ren C, et al
   Ultrasound-guided, indocyanine green-directed robot-assisted surgery for breast cancer with negative margins: A single center study.
   Eur J Surg Oncol. 2026;52:111445.
   PubMed     Abstract available
   
   
   
6. BARRANGER E, Najib B, Dejean C, Jacquinot F, et al
   Iodine(125) grain isotope detection compared to standard metal guide detection for breast cancers: The IODINE BREAST, a randomised, non-inferiority trial.
   Eur J Surg Oncol. 2026;52:111376.
   PubMed     Abstract available
   
   
   
7. KETLEY A, Martin C, Wyld L, King N, et al
   What makes a 'good' mastectomy? - A national qualitative study of health care professionals opinions on mastectomy without reconstruction.
   Eur J Surg Oncol. 2026;52:111333.
   PubMed     Abstract available
   
   
   
8. ZEHNPFENNIG L, Maggi N, Levy J, Loesch JM, et al
   Post-mastectomy radiotherapy negatively impacts short-term patient-reported outcomes in patients with and without immediate breast reconstruction - a retrospective cohort study.
   Eur J Surg Oncol. 2026;52:111305.
   PubMed     Abstract available
   
   
   January 2026
9. LEE ES, Calindas-Mendoza MR, Jung SP, Moon HG, et al
   Differential prognostic impact of clinicopathologic factors for late recurrence in ER-positive breast cancer according to menopausal status.
   Eur J Surg Oncol. 2026;52:111419.
   PubMed     Abstract available
   
   
   
10. ALVAREZ-LOZADA LA, Salinas-Martinez AM, Pena-Arriaga MD, Valencia-Mercado D, et al
    Meeting expectations and its impact on the quality of life following surgery in breast cancer patients.
    Eur J Surg Oncol. 2026;52:111421.
    PubMed     Abstract available
    
    
    
11. YU X, Zhang C, Fu M
    The European burden of breast cancer in 2022.
    Eur J Surg Oncol. 2026;52:111420.
    PubMed     Abstract available
    
    
    
12. POTTER S, MacKenzie M, McIntosh S, Gathani T, et al
    Reducing locoregional treatments in low risk early invasive breast cancer.
    Eur J Surg Oncol. 2026;52:111411.
    PubMed     Abstract available
    
    
    
13. NANDA A, Marshall E, Attia M, Alaradi D, et al
    Targeted axillary dissection after neoadjuvant chemotherapy in breast cancer patients with a high lymph node burden: Radiological and histological outcomes.
    Eur J Surg Oncol. 2026;52:111393.
    PubMed     Abstract available
    
    
    
14. ADDIE M, Miron AD, Iny E, Wong SM, et al
    Patients with positive axillary nodes undergoing upfront surgery: Can axillary dissection be safely omitted?
    Eur J Surg Oncol. 2026;52:111304.
    PubMed     Abstract available
    
    
    December 2025
15. LOI F, Rassy E, Grinda T, Puchar A, et al
    Targeted axillary dissection in breast cancer: current evidence and ongoing trials.
    Eur J Surg Oncol. 2025;52:111377.
    PubMed     Abstract available
    
    
    
16. SNELLEN TIM, Baas GSNJ, Scholten AN, Dezentje VO, et al
    Tailoring axillary treatment in patients with isolated locoregional recurrent breast cancer.
    Eur J Surg Oncol. 2025;52:111375.
    PubMed     Abstract available
    
    
    
17. KIM KJ, Kang E, Baek SH, Lee HB, et al
    Alteration in estrogen receptor status in metachronous contralateral breast cancer among unilateral early breast cancer patients with BRCA 1/2 mutations.
    Eur J Surg Oncol. 2025;52:111332.
    PubMed     Abstract available
    
    
    
18. WANG S, Zhang H, Lin J, Meng H, et al
    Clinical efficacy and psychological benefits of ultrasound-guided vacuum-assisted excision in outpatient management of benign breast lesions.
    Eur J Surg Oncol. 2025;51:110498.
    PubMed     Abstract available
    
    
    
19. PISARCIK D, Heimer J, Farkas M, Kubik-Huch RA, et al
    Qualitative and quantitative analysis of stereotactic-guided positioning of the Pintuition marker in pre-surgical localization of non-palpable breast lesions.
    Eur J Surg Oncol. 2025;51:110495.
    PubMed     Abstract available
    
    
    
20. SCHOENEN S, Martinez Gomez C, Pasquesoone C, Alline J, et al
    Evaluation of risk-reducing radical fimbriectomy followed by delayed oophorectomy in high-risk Women: A single-center retrospective study.
    Eur J Surg Oncol. 2025;51:110469.
    PubMed     Abstract available
    
    
    
21. MOUAWAD J, French J, Meybodi F, Stuart K, et al
    Breast sensation following nipple-sparing mastectomy versus breast-conserving surgery: a mixed-methods study.
    Eur J Surg Oncol. 2025;51:110477.
    PubMed     Abstract available
    
    
    
22. BARJOT C, Gaillard T, Seban RD, Darrigues L, et al
    Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgery.
    Eur J Surg Oncol. 2025;51:110511.
    PubMed     Abstract available
    
    
    November 2025
23. SHAH S, Manor KA, Shaker H, Harvey J, et al
    Breast Cancer After Breast Augmentation study (BCABA): A national multicentre collaborative study of patient management and outcomes.
    Eur J Surg Oncol. 2025;52:111306.
    PubMed     Abstract available
    
    
    
24. LOAP P, Cheptea C, Kirova Y
    Feasibility of a third breast-conserving treatment in ipsilateral breast cancer recurrence: A retrospective population-based analysis.
    Eur J Surg Oncol. 2025;52:111184.
    PubMed     Abstract available
    
    
    
25. LUCOCQ J, Baig H, Michael Dixon J
    The impact of immediate lipofilling on oncological outcomes, complication rates and patient reported outcomes in breast conserving surgery: a systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110446.
    PubMed     Abstract available
    
    
    
26. REID A, Sibbering L, Burridge I, Kalra L, et al
    Chest wall perforator flaps for partial breast reconstruction: An observational cohort study of 290 women to evaluate clinical and oncological outcomes.
    Eur J Surg Oncol. 2025;51:110430.
    PubMed     Abstract available
    
    
    
27. KIRWAN CC, Hilton B, Clements K, Dodwell D, et al
    Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates.
    Eur J Surg Oncol. 2025;51:110431.
    PubMed     Abstract available
    
    
    October 2025
28. TSUJI W, Sasada S, Watanabe N, Tomita S, et al
    Effectiveness of post-mastectomy radiation therapy after breast reconstruction for patients with high-risk breast cancer: A retrospective multicenter cohort study (Reborn study-03).
    Eur J Surg Oncol. 2025;52:110523.
    PubMed     Abstract available
    
    
    
29. WANG Y, Zhan J, Liu S, Chen M, et al
    Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis.
    Eur J Surg Oncol. 2025;51:110496.
    PubMed     Abstract available
    
    
    
30. CLIFFORD JT, Ryan OK, Donnelly M, Davey M, et al
    From obesity to oncology; bariatric surgery and the impact on breast cancer- what is the link? - A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110478.
    PubMed     Abstract available
    
    
    
31. SCHULTEK G, Gerber B, Hartmann S, Reimer T, et al
    Clinical implications of clip migration after stereotactic-assisted vacuum-assisted breast biopsies.
    Eur J Surg Oncol. 2025;51:110393.
    PubMed     Abstract available
    
    
    
32. MOLSKA M, Wojciech M, Pieszko K, Ciesla S, et al
    Randomized controlled trial comparing single-use negative-pressure wound therapy (sNPWT) with standard dressings during tissue expander-to-implant exchanges. Assessment of risk factors for impaired wound healing and clinical indications for sNPWT.
    Eur J Surg Oncol. 2025;51:110355.
    PubMed     Abstract available
    
    
    
33. KAIDAR-PERSON O, Poortmans P, Offersen BV, Meattini I, et al
    Optimising mastectomy with a focus on skin and nipple-sparing approaches: a multidisciplinary point of view.
    Eur J Surg Oncol. 2025;51:110310.
    PubMed     Abstract available
    
    
    
34. HAMANN M, Bensmann E, Andrulat A, Festl J, et al
    Real-world quality of life outcomes after prepectoral implant-based breast reconstruction with or without titanium-coated mesh (TiLOOP(R) Bra Pocket): A prospective cohort study.
    Eur J Surg Oncol. 2025;51:110311.
    PubMed     Abstract available
    
    
    
35. SANCHEZ AM, De Lauretis F, Bucaro A, Pirrottina CV, et al
    Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM * study group. ( *the breast European association for mesenchymal tumors).
    Eur J Surg Oncol. 2025;51:110265.
    PubMed     Abstract available
    
    
    September 2025
36. HANNOUN-LEVI JM, Margenthaler J, Anderson B, Di Micco R, et al
    Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective.
    Eur J Surg Oncol. 2025;51:110484.
    PubMed     Abstract available
    
    
    
37. CHONG K, Azmy I, Al-Shurbasi N, Hollywood C, et al
    Enhancing compliance and decision-making in breast cancer care for older adults: Optimising the NABCOP fitness assessment form.
    Eur J Surg Oncol. 2025;51:110475.
    PubMed     Abstract available
    
    
    
38. LEE CE, Nam SJ, Kim SW, Yu J, et al
    Re-evaluating the necessity of removing residual calcifications detected after surgery in HR-/HER2+ breast cancer with pathologic complete response.
    Eur J Surg Oncol. 2025;51:110476.
    PubMed     Abstract available
    
    
    
39. REIMER T, Kuehn T, Mueller V, Ditsch N, et al
    AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
    Eur J Surg Oncol. 2025;51:110445.
    PubMed     Abstract available
    
    
    
40. CREWE E, Tyrer F, Deanfield J, de Belder M, et al
    Geographic variation in surgery rates among older patients with early (ER positive HER2 negative) breast cancer: Influence of cardiovascular disease and comorbidities: A national registry dataset analysis.
    Eur J Surg Oncol. 2025;51:110432.
    PubMed     Abstract available
    
    
    
41. MICHOT A, Giraud A, Karanian M, Lae M, et al
    Radiation-associated angiosarcoma of the breast: consider chemotherapy.
    Eur J Surg Oncol. 2025;51:110202.
    PubMed     Abstract available
    
    
    
42. JAVAID H, Marin I, Montalvan J, Healy L, et al
    Current options and future perspectives for margin assessment in breast conservation surgery.
    Eur J Surg Oncol. 2025;51:110215.
    PubMed     Abstract available
    
    
    
43. PERMUTT A, Patel R, Thiruchelvam PT, Leff DR, et al
    Immediate or delayed contralateral symmetrisation in therapeutic mammoplasty-A systematic review.
    Eur J Surg Oncol. 2025;51:110226.
    PubMed     Abstract available
    
    
    
44. DINCER B, Yukruk FA, Irkkan SC, Kaya C, et al
    Does surgical margin status truly affect local recurrence in benign and borderline phyllodes tumors of the breast?
    Eur J Surg Oncol. 2025;51:110195.
    PubMed     Abstract available
    
    
    
45. GELDART J, Barrett E, Morad A, Harvey J, et al
    Timing matters: A comparative analysis of synchronous and metachronous mammoplasty techniques.
    Eur J Surg Oncol. 2025;51:110109.
    PubMed     Abstract available
    
    
    August 2025
46. ABDULLAYEV N, Kottlors J, Habibov H, Yilmaz F, et al
    European guideline informed RAG-based GPT-4 decision support tool in tumor board meetings for breast cancer treatment.
    Eur J Surg Oncol. 2025;51:110384.
    PubMed     Abstract available
    
    
    
47. TAUBER N, Rambow AC, Gasthaus C, Fick F, et al
    Axillary surgery in early breast cancer: real-world analysis of the INSEMA-trial at three certified university breast cancer centers in Germany regarding the omission of sentinel lymph node biopsy.
    Eur J Surg Oncol. 2025;51:110392.
    PubMed     Abstract available
    
    
    
48. VAN ZEELST LJ, van Eekeren RRJP, van Uden DJP, Schok T, et al
    Patient-reported long-term outcomes after mastectomy, comparing the quilt technique to the conventional method.
    Eur J Surg Oncol. 2025;51:110278.
    PubMed     Abstract available
    
    
    
49. SONI A, Morgan J, Jacques R, Wyld L, et al
    Trends in the rate of axillary clearance following the publication of the ACOSOG Z0011 trial: A systematic review.
    Eur J Surg Oncol. 2025;51:110023.
    PubMed     Abstract available
    
    
    
50. FERRUCCI M, Passeri D, Milardi F, Marchet A, et al
    Clinical management and oncologic outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: Results from a large single institution experience.
    Eur J Surg Oncol. 2025;51:110021.
    PubMed     Abstract available
    
    
    
51. PEREIRA DE GODOY HJ, Pereira de Godoy JM
    Comments on: The efficacy of immediate lymphatic reconstruction after axillary lymph node dissection - A meta-analysis. Wong AW, Sim NHS, Zhan SJ, Huang JJ.
    Eur J Surg Oncol. 2025;51:109698.
    PubMed     Abstract available
    
    
    July 2025
52. DALTON L, Rakha E
    Transcriptomic classifiers do not reliably predict lymph node involvement in breast Cancer: Insights from three large cohorts.
    Eur J Surg Oncol. 2025;51:110354.
    PubMed     Abstract available
    
    
    
53. ZABOROWSKI AM, McGarry J, Wehrmann F, Ryan EJ, et al
    Oncological outcomes of sentinel lymph node biopsy alone in patients with residual nodal disease after neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:110356.
    PubMed     Abstract available
    
    
    
54. YU SWY, Ho CM, Kwok C, Soong I, et al
    Reply to: Comment on "Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction".
    Eur J Surg Oncol. 2025 Jul 17:110314. doi: 10.1016/j.ejso.2025.110314.
    PubMed    
    
    
    
55. SHIN DS, Park J, Lee H, Park WK, et al
    Potential for omitting sentinel lymph node biopsy in patients with human epidermal growth factor receptor 2-positive or triple negative breast cancer with non-breast pCR after neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2025;51:110331.
    PubMed     Abstract available
    
    
    
56. ZHANG W, Ge Q
    Comment on "Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction".
    Eur J Surg Oncol. 2025;51:110313.
    PubMed    
    
    
    
57. WOOLDRIK S, van de Voort EF, Struik G, Schouten BM, et al
    Cosmetic outcome and patient satisfaction following percutaneous thermal ablation of early-stage breast cancer; results of an open label randomized phase 2 trial.
    Eur J Surg Oncol. 2025;51:110305.
    PubMed     Abstract available
    
    
    
58. VILA J, Farante G, Ripoll-Orts F, Lissidini G, et al
    A retrospective study evaluating surgical upstaging rates in low-risk DCIS patients meeting the eligibility criteria for active surveillance trials.
    Eur J Surg Oncol. 2025;51:109716.
    PubMed     Abstract available
    
    
    
59. ALGHAZAWI LOK, Mavroveli S, Anastasiou E, Attia M, et al
    Validation of a simulator for oncoplastic breast conserving surgery.
    Eur J Surg Oncol. 2025;51:109753.
    PubMed     Abstract available
    
    
    June 2025
60. NERO DDSM, Lira CRN, Paz CLDSL, Costa PRF, et al
    Effect of physical exercise on the quality of life of women surviving breast cancer: systematic review with meta-analysis of randomized clinical trials.
    Eur J Surg Oncol. 2025;51:110287.
    PubMed     Abstract available
    
    
    
61. HARTMANN S, Banys-Paluchowski M, Berger T, Ditsch N, et al
    Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655).
    Eur J Surg Oncol. 2025;51:110253.
    PubMed     Abstract available
    
    
    
62. MARTIN-GARCIA D, Garcia-Aranda M, Varela-Moreno E, Padilla-Ruiz M, et al
    Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study.
    Eur J Surg Oncol. 2025;51:110280.
    PubMed     Abstract available
    
    
    
63. ELFGEN C, Niemeyer M, Leo C, Sager P, et al
    Surgical MArker Localization OR clip and wire application for targeted axillary dissection in node-positive breast cancer patients - Results from the randomized superiority MALLORCA-trial.
    Eur J Surg Oncol. 2025;51:110266.
    PubMed     Abstract available
    
    
    
64. GULCELIK MA, Dogan L, Karanlik H, Akinci M, et al
    Profile of surgical complications and complication-led reoperation rates in breast cancer patients who underwent oncoplastic breast surgery with volume displacements.
    Eur J Surg Oncol. 2025;51:110252.
    PubMed     Abstract available
    
    
    
65. VASILEVA-SLAVEVA M, Yordanov A, Ivanov I, Nanev V, et al
    Corrigendum to "Prognosis of rare histological subtypes of breast cancer - insights from the Bulgarian National Cancer Registry" [Eur. J. Surg. Oncol. 51:4 (2025) 109712].
    Eur J Surg Oncol. 2025;51:110190.
    PubMed    
    
    
    
66. PERADZE N, Polizzi A, Pagan E, Bottazzoli E, et al
    Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes.
    Eur J Surg Oncol. 2025;51:109714.
    PubMed     Abstract available
    
    
    
67. BOLAND MR, Pantiora E, Rutherford C, Evoy D, et al
    Use of superparamagnetic iron oxide for sentinel lymph node detection following neoadjuvant systemic therapy. A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;51:109684.
    PubMed     Abstract available
    
    
    
68. MATILAINEN S, Liikanen H, Lassila R, Laitinen MK, et al
    Assessing the diagnostic value of oncological biomarkers for identifying primary malignancies in skeletal metastatic disease.
    Eur J Surg Oncol. 2025;51:109688.
    PubMed     Abstract available
    
    
    
69. LI Z, Wang F, Kou X, Couban RJ, et al
    Intercostobrachial nerve preservation during breast cancer surgery to prevent chronic postsurgical pain: A systematic review and meta-analysis of randomized controlled trials.
    Eur J Surg Oncol. 2025;51:110214.
    PubMed     Abstract available
    
    
    May 2025
70. WOOLDRIK SM, Riks L, Struik GM, Hulsebosch F, et al
    Reply to: Additional breast lesions on MRI in patients with small early-stage luminal-type breast cancer: Implications for future thermal ablation treatment.
    Eur J Surg Oncol. 2025;51:110172.
    PubMed    
    
    
    
71. AHMED IA, Bano S
    Additional breast lesions on MRI in patients with small early-stage luminal-type breast cancer: Implications for future thermal ablation treatment.
    Eur J Surg Oncol. 2025;51:110173.
    PubMed    
    
    
    
72. VANNI G, Pellicciaro M, Materazzo M, Petrucci S, et al
    The role of sentinel lymph biopsy in patients with microinvasive breast cancer: A multicentric study.
    Eur J Surg Oncol. 2025;51:109601.
    PubMed     Abstract available
    
    
    
73. XIU B, Zhang Q, Meng X, Hao S, et al
    Current practices and challenges of endoscopic-assisted breast surgery in China: A nationwide cross-sectional survey.
    Eur J Surg Oncol. 2025;51:109620.
    PubMed     Abstract available
    
    
    
74. MOK CW
    Cost-effectiveness of robotic mastectomy vs. conventional mastectomy: A long-term economic evaluation from a Singapore healthcare perspective.
    Eur J Surg Oncol. 2025;51:109608.
    PubMed     Abstract available
    
    
    
75. WALSTRA CJEF, Schipper RJ, Voogd AC, van der Sangen MJC, et al
    The role of (18)F-FDG PET/CT in detecting synchronous regional and distant metastatic disease in patients with an in-breast tumour recurrence.
    Eur J Surg Oncol. 2025;51:109564.
    PubMed     Abstract available
    
    
    April 2025
76. YU SWY, Ho CM, Kwok C, Soong I, et al
    Pre-operative radiotherapy for breast cancer patients receiving mastectomy and immediate autologous tissue reconstruction.
    Eur J Surg Oncol. 2025;51:110110.
    PubMed     Abstract available
    
    
    
77. SONI A, Morgan J, Wyld L
    A qualitative study exploring the views of global healthcare professionals towards de-escalation of axillary surgery in early breast cancer.
    Eur J Surg Oncol. 2025;51:110079.
    PubMed     Abstract available
    
    
    
78. GATHANI T, Kan SW, Sweetland S, Reeves G, et al
    Reply to: Advancing equity in breast cancer detection: A public health and primary care imperative.
    Eur J Surg Oncol. 2025 Apr 12:110053. doi: 10.1016/j.ejso.2025.110053.
    PubMed    
    
    
    
79. KOH HW, Jung JJ, Kim HK, Moon HG, et al
    Tumor volume as a predictor of recurrence-free survival, but not overall survival, in early breast cancer.
    Eur J Surg Oncol. 2025;51:110024.
    PubMed     Abstract available
    
    
    
80. VASILEVA-SLAVEVA M, Yordanov A, Ivanov I, Nanev V, et al
    Prognosis of rare histological subtypes of breast cancer - insights from the Bulgarian National Cancer Registry.
    Eur J Surg Oncol. 2025 Apr 11:109712. doi: 10.1016/j.ejso.2025.109712.
    PubMed     Abstract available
    
    
    
81. JERJES W
    Advancing equity in breast cancer detection: A public health and primary care Imperative.
    Eur J Surg Oncol. 2025 Apr 11:110052. doi: 10.1016/j.ejso.2025.110052.
    PubMed    
    
    
    
82. PARK WK, Nam SJ, Kim SW, Yu J, et al
    Real-world evidence of the efficacy of neoadjuvant pembrolizumab in triple-negative breast cancer: A surgeon's point of view.
    Eur J Surg Oncol. 2025;51:110011.
    PubMed     Abstract available
    
    
    March 2025
83. ZHANG W
    Comment on "Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based study".
    Eur J Surg Oncol. 2025;51:110002.
    PubMed    
    
    
    
84. CHIA Z, O'Brien M, Shortland J, Holmes HM, et al
    The influence of physical post-operative rehabilitation interventions to improve upper limb strength in women undergoing breast cancer surgery: A Systematic Review of the literature.
    Eur J Surg Oncol. 2025;51:109983.
    PubMed     Abstract available
    
    
    
85. CASELLA D, Rocco N, Sordi S, Catanuto G, et al
    The LyBra score: A risk assessment tool to address targeted prevention against breast cancer - Related lymphedema.
    Eur J Surg Oncol. 2025;51:109754.
    PubMed     Abstract available
    
    
    
86. CORSI F, Cabri GF, Albasini S, Bossi D, et al
    Management of B3 breast lesions: Potential clinical implications from a retrospective study conducted in an accredited Breast Unit following the 2024 EUSOMA guidelines.
    Eur J Surg Oncol. 2025;51:109579.
    PubMed     Abstract available
    
    
    
87. HYLDEBRANDT HK, Stormorken AT, Vitelli V, Maehle L, et al
    Risk reducing mastectomy in Norwegian BRCA1/2 carriers.
    Eur J Surg Oncol. 2025;51:109571.
    PubMed     Abstract available
    
    
    
88. LEROY E, Poirier L, Planque H, Le Brun JF, et al
    Time to reconsider the use of synthetic mesh in immediate prepectoral implant-based breast reconstruction: Impact of their use on short-term outcomes.
    Eur J Surg Oncol. 2025;51:108780.
    PubMed     Abstract available
    
    
    February 2025
89. LUCOCQ J, Baig H, McNeill E, Dixon JM, et al
    The efficacy and oncological safety of minimally invasive axillary procedures in patients with node-positive breast cancer receiving neoadjuvant chemotherapy: A network meta-regression and trial sequential analysis.
    Eur J Surg Oncol. 2025;51:109689.
    PubMed     Abstract available
    
    
    
90. WOOLDRIK SM, Riks L, Struik GM, Hulsebosch F, et al
    Additional breast lesions on MRI in patients with small early stage luminal type breast cancer: Important consequences for future thermal ablation treatment.
    Eur J Surg Oncol. 2025;51:109715.
    PubMed     Abstract available
    
    
    January 2025
91. CABIOGLU N, Karanlik H, Igci A, Uras C, et al
    Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study.
    Eur J Surg Oncol. 2025;51:109642.
    PubMed     Abstract available
    
    
    
92. CATANUTO G, Gentile D, Martorana F, Tomatis M, et al
    Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database.
    Eur J Surg Oncol. 2025;51:109643.
    PubMed     Abstract available
    
    
    
93. FU M, Peng Z, Wu M, Lv D, et al
    Assessing the African burden of breast cancer: A demographic analysis using Global Cancer Observatory 2022.
    Eur J Surg Oncol. 2025;51:109627.
    PubMed     Abstract available
    
    
    
94. KUO WL, Huang JJ, Chu CH, Chang SC, et al
    Comparative analysis of oncological and surgical outcomes of robotic versus conventional mastectomy for breast cancer.
    Eur J Surg Oncol. 2025;51:109622.
    PubMed     Abstract available
    
    
    
95. GORDON AB, Sheeka A, Cleator S, Leff D, et al
    Tumour volume analysis applied to imaging and histological examinations in breast cancer.
    Eur J Surg Oncol. 2025;51:109578.
    PubMed     Abstract available
    
    
    
96. LIU X, Eriksson Bergman L, Boman C, Foukakis T, et al
    Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based study.
    Eur J Surg Oncol. 2025 Jan 7:109587. doi: 10.1016/j.ejso.2025.109587.
    PubMed     Abstract available
    
    
    
97. T G, Sw K, S S, Gk R, et al
    Ethnicity and breast cancer incidence in over 329 500 women in England in 2011-2019.
    Eur J Surg Oncol. 2025 Jan 6:109585. doi: 10.1016/j.ejso.2025.109585.
    PubMed     Abstract available
    
    
    
98. GATHANI T, Kan SW, Sweetland S, Reeves G, et al
    Ethnicity and breast cancer incidence in over 329,500 women in England in 2011-2019.
    Eur J Surg Oncol. 2025 Jan 6. doi: 10.1016/j.ejso.2025.109585.
    PubMed     Abstract available
    
    
    
99. WONG AW, Sim NHS, Zhan SJ, Huang JJ, et al
    The efficacy of immediate lymphatic reconstruction after axillary lymph node dissection - A meta-analysis.
    Eur J Surg Oncol. 2025;51:109377.
    PubMed     Abstract available
    
    
    
100. JAZRAWI A, Pantiora E, Abdsaleh S, Ng CL, et al
     Prospective evaluation of MRI artefacts following breast conserving surgery and sentinel lymph node dissection with the magnetic technique.
     Eur J Surg Oncol. 2025;51:109368.
     PubMed     Abstract available
     
     
     
101. LUKAC S, Leinert E, Kuhn T, Dayan D, et al
     Eco-logistical comparison of non-radioactive seeds and the wire-guided localization for intraoperative detection of breast lesions.
     Eur J Surg Oncol. 2025;51:108779.
     PubMed     Abstract available
     
     
     December 2024
102. VISWANATHAN D, Govindasamy R
     ERD-1233: A potent and orally active oestrogen receptor PROTAC degrader for treating ER+ breast cancer.
     Eur J Surg Oncol. 2024;51:109567.
     PubMed    
     
     
     
103. BOUZIANE J, Loap P, Cao K, Pauly L, et al
     Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approach.
     Eur J Surg Oncol. 2024;51:109555.
     PubMed     Abstract available
     
     
     
104. GENNARO M, Mariani L, Palassini E, Stacchiotti S, et al
     Timeline of surgery in localized angiosarcoma of the breast: Improving outcome following multidisciplinary treatment optimization.
     Eur J Surg Oncol. 2024;50:108699.
     PubMed     Abstract available
     
     
     
105. MITCHELL MP, Shaitelman SF, Smith BD, Krishnamurthy S, et al
     Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy.
     Eur J Surg Oncol. 2024;50:108613.
     PubMed     Abstract available
     
     
     November 2024
106. AIN Q, O'Connell RL, Swarnkar P, McVeigh T, et al
     Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation.
     Eur J Surg Oncol. 2024;51:109380.
     PubMed     Abstract available
     
     
     
107. FTEROPOULLI T, Tzounaka E, Amirova A, Nikolopoulos G, et al
     Changes in health-related quality of life following breast cancer surgery: A systematic review of the literature on the role of surgical approaches.
     Eur J Surg Oncol. 2024 Nov 16:109467. doi: 10.1016/j.ejso.2024.109467.
     PubMed     Abstract available
     
     
     
108. LAAS E, Dumas E, Hamy AS, Gaillard T, et al
     The influence of treatment intervals on prognosis in young breast cancer patients: Insights from the French National cohort.
     Eur J Surg Oncol. 2024;51:109373.
     PubMed     Abstract available
     
     
     
109. PARK WK, Kim HJ, Ryu JM, Chae BJ, et al
     Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes.
     Eur J Surg Oncol. 2024;50:108644.
     PubMed     Abstract available
     
     
     October 2024
110. ALLOTEY J, Ruparel V, McCallum A, Somal K, et al
     Residual microcalcifications after neoadjuvant systemic therapy for early breast cancer: Implications for surgical planning and long-term outcomes.
     Eur J Surg Oncol. 2024;51:108781.
     PubMed     Abstract available
     
     
     
111. GENTILE D, Martorana F, Karakatsanis A, Caruso F, et al
     Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study.
     Eur J Surg Oncol. 2024;50:108732.
     PubMed     Abstract available
     
     
     
112. JUNG SM, Kim YJ, Lee KT, Jeon BJ, et al
     Learning curve for robot-assisted nipple-sparing mastectomy: A single institution experience.
     Eur J Surg Oncol. 2024;50:108602.
     PubMed     Abstract available
     
     
     
113. ALHUSSINI MA, Mohamed SM, Elfayoumi T, El-Damati AM, et al
     Goldilocks mastectomy; a modified technique enhancing the aesthetic outcome presented as a single center single-arm prospective cohort study.
     Eur J Surg Oncol. 2024;50:108586.
     PubMed     Abstract available
     
     
     
114. ARISTOKLEOUS I, Pantiora E, Sjokvist O, Karakatsanis A, et al
     The value of patient-reported experience in oncoplastic breast conservation following standardized assessment and shared-decision making. A qualitative study.
     Eur J Surg Oncol. 2024;50:108524.
     PubMed     Abstract available
     
     
     September 2024
115. LIU W, An J, Jiao C
     Reply to Letter to the Editor "the association between physical activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020".
     Eur J Surg Oncol. 2024;50:108709.
     PubMed    
     
     
     
116. ZHANG P, Guo M, Huang P
     Letter to the Editor "The association between physical activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020".
     Eur J Surg Oncol. 2024;50:108710.
     PubMed    
     
     
     
117. LONIE S, Crowley TP, Howitt R, Dildey P, et al
     Malignant phyllodes: 10 year review of management through a sarcoma service.
     Eur J Surg Oncol. 2024;50:108534.
     PubMed     Abstract available
     
     
     
118. GIULIANI G, Vitale R, Brunetti N, Ninniri C, et al
     Non-palpable breast lesions localization techniques - A new priority: Results of a Senonetwork survey among breast centers in Italy.
     Eur J Surg Oncol. 2024;50:108471.
     PubMed     Abstract available
     
     
     
119. HEIDINGER M, Loesch JM, Levy J, Maggi N, et al
     Association of relative resection volume with patient-reported outcomes applying different levels of oncoplastic breast conserving surgery - A retrospective cohort study.
     Eur J Surg Oncol. 2024;50:108478.
     PubMed     Abstract available
     
     
     
120. SEN A, Jacob AT, Bhargavan R, Augustine P, et al
     Pre-chemotherapy clinically-guided skin tattooing + post-chemotherapy USG-guided skin marking: A time-tested, cost-effective technique for breast lesion localization, before Breast Conservation Surgery (BCS), in a high volume tertiary care cancer hosp
     Eur J Surg Oncol. 2024;50:108371.
     PubMed    
     
     
     
121. SARKAR DK
     Pre-chemotherapy clinically-guided skin tattooing + post-chemotherapy USG-guided skin marking: A time-tested, cost-effective technique for breast lesion localization, before Breast Conservation Surgery (BCS), in a high volume tertiary care cancer hosp
     Eur J Surg Oncol. 2024;50:108370.
     PubMed     Abstract available
     
     
     August 2024
122. LIU W, An J, Jiao C, Zhi L, et al
     The Association Between Physical Activity and risk for breast cancer in US female adults: A cross-sectional study based on NHANES 2011-2020.
     Eur J Surg Oncol. 2024;50:108647.
     PubMed     Abstract available
     
     
     
123. KAIDAR-PERSON O, Sklair-Levy M, Anaby D, Bernstein-Molho R, et al
     Residual breast tissue after mastectomy and reconstruction: A substudy of the Spatial location of breast cancer local rECurRence aftEr masTectomy (SECRET) project.
     Eur J Surg Oncol. 2024;50:108607.
     PubMed     Abstract available
     
     
     
124. CABALLERO C, Lundon DJ, Vasileva-Slaveva M, Montagna G, et al
     A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
     Eur J Surg Oncol. 2024;50:108585.
     PubMed     Abstract available
     
     
     
125. DOWN S, Sandelin K, Wyld L, MacNeill F, et al
     Debate article: Management of breast cancer in patients with pre-existing bilateral breast augmentation-a snapshot of global practice and call for international guidelines.
     Eur J Surg Oncol. 2024;50:108606.
     PubMed     Abstract available
     
     
     
126. CORTESI L, Cortesi G, Venturelli M, Marcheselli L, et al
     Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study.
     Eur J Surg Oncol. 2024;50:108603.
     PubMed     Abstract available
     
     
     
127. JOHNSON MC, McGregor AH, A'Hern R, Leff DR, et al
     'I presumed the pain would eventually get better by itself'; challenges with access to rehabilitation for upper limb dysfunction after breast cancer treatment - Descriptive and qualitative findings from a cross-sectional survey.
     Eur J Surg Oncol. 2024;50:108591.
     PubMed     Abstract available
     
     
     
128. RAKHA EA, Quinn C, Masannat YA, Lee AS, et al
     Revisiting surgical margins for invasive breast cancer patients treated with breast conservation therapy - Evidence for adopting a 1 mm negative width.
     Eur J Surg Oncol. 2024;50:108573.
     PubMed     Abstract available
     
     
     July 2024
129. JIANG M, Avery K, Ahmed R, de Boniface J, et al
     Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review.
     Eur J Surg Oncol. 2024;50:108554.
     PubMed     Abstract available
     
     
     
130. GEDFEW M, Getie A, Akalu TY, Ayenew T, et al
     Recurrence and associated factors of breast cancer among women in sub saharan africa, systematic review and meta-analysis.
     Eur J Surg Oncol. 2024;50:108528.
     PubMed     Abstract available
     
     
     
131. GILL SS, Shukla A, Namireddy SR, Moin S, et al
     Exercise and recovery after surgery in patients with breast cancer: An analysis of the literature.
     Eur J Surg Oncol. 2024;50:108525.
     PubMed     Abstract available
     
     
     
132. SCHIAVONE A, Ventimiglia F, Zarba Meli E, Taffurelli M, et al
     Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus.
     Eur J Surg Oncol. 2024;50:108351.
     PubMed     Abstract available
     
     
     June 2024
133. SCHIPPER RJ, de Bruijn A, van der Sangen MJC, Bloemen JG, et al
     Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study.
     Eur J Surg Oncol. 2024;50:108472.
     PubMed     Abstract available
     
     
     
134. PLOUMEN RAW, Claassens EL, Kooreman LFS, Keymeulen KBMI, et al
     Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
     Eur J Surg Oncol. 2024;50:108465.
     PubMed     Abstract available
     
     
     
135. SPOOR J, Heeling E, Collewijn RC, van der Ploeg IMC, et al
     Intraoperative frozen section of subareolar tissue in nipple-sparing mastectomy: Towards a less is more approach.
     Eur J Surg Oncol. 2024;50:108320.
     PubMed     Abstract available
     
     
     May 2024
136. YEO HAO XUAN M, Masuda Y
     Reply to: Surgery vs. non-surgery for liver metastases from primary breast cancer.
     Eur J Surg Oncol. 2024 May 29:108446. doi: 10.1016/j.ejso.2024.108446.
     PubMed    
     
     
     
137. HAN W, Shi CT, Wang HN
     Surgery vs. non-surgery for liver metastases from primary breast cancer.
     Eur J Surg Oncol. 2024 May 28:108445. doi: 10.1016/j.ejso.2024.108445.
     PubMed    
     
     
     
138. SAQIB HWU, Arshad HUA
     "Navigating breast cancer treatment: The role of early genetic testing".
     Eur J Surg Oncol. 2024;50:108392.
     PubMed    
     
     
     April 2024
139. SASADA S, Nagura N, Shimo A, Ogiya A, et al
     Impact of radiation therapy for breast cancer with involved surgical margin after immediate breast reconstruction: A multi-institutional observational study.
     Eur J Surg Oncol. 2024;50:108360.
     PubMed     Abstract available
     
     
     
140. OGIYA A, Kimura K, Ueno T, Iwase T, et al
     Time trend of breast cancer-related lymphedema according to body mass index.
     Eur J Surg Oncol. 2024;50:108350.
     PubMed     Abstract available
     
     
     
141. APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
     Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
     Eur J Surg Oncol. 2024;50:108324.
     PubMed     Abstract available
     
     
     
142. NAVARRO AS, Omalek D, Chaltiel L, Vaysse C, et al
     Oncologic safety of autologous fat grafting in primary breast reconstruction after mastectomy for cancer.
     Eur J Surg Oncol. 2024;50:107998.
     PubMed     Abstract available
     
     
     
143. MEATTINI I, Kunkler IH
     Omission of radiation therapy after breast conserving surgery for older women at low-risk of local recurrence: One option among many.
     Eur J Surg Oncol. 2024;50:108058.
     PubMed     Abstract available
     
     
     
144. SAE-LIM C, Lai HW, Lin SL, Huang HI, et al
     Is minimal-accessed (endoscopic- or robotic-assisted) nipple-sparing mastectomy contraindicated for large breasts?
     Eur J Surg Oncol. 2024;50:108030.
     PubMed     Abstract available
     
     
     March 2024
145. TASOULIS MK, Muktar S, Smith I, Roche N, et al
     Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy.
     Eur J Surg Oncol. 2024;50:108277.
     PubMed     Abstract available
     
     
     
146. DI LENA E, Wong SM, Iny E, Mashal S, et al
     Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study.
     Eur J Surg Oncol. 2024;50:108266.
     PubMed     Abstract available
     
     
     
147. LOVELAND-JONES C, Gaughan J, Caudle A, Murphy B, et al
     Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry.
     Eur J Surg Oncol. 2024;50:108245.
     PubMed     Abstract available
     
     
     February 2024
148. SKJERVEN HK, Myklebust EM, Korvald C, Stubberud K, et al
     Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.
     Eur J Surg Oncol. 2024;50:107938.
     PubMed     Abstract available
     
     
     
149. VAN DAM MA, Bijlstra OD, Faber RA, Warmerdam MI, et al
     Consensus conference statement on fluorescence-guided surgery (FGS) ESSO course on fluorescence-guided surgery.
     Eur J Surg Oncol. 2024;50:107317.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum